What is the market's earnings forecast for Alcon next quarter?

What guidance did Alcon's management provide for the next earnings period?

Did Alcon beat or miss consensus estimates last quarter?

What is the revenue and EPS growth rate for Alcon year over year?

What were the key takeaways from Alcon’s earnings call?

What were the key takeaways from Alcon's earnings call?

What is Alcon's gross profit margin?

What factors drove the changes in Alcon's revenue and profit?

- **Revenue Beat Expectations**: Q3 $2.6B (+5% YoY), driven by Surgical and Vision Care growth.
- **Unity VCS Leadership**: 1,200 placements YTD, with 2026 equipment growth acceleration.
- **Profit Margin Challenges**: 2026 tariffs to pressure margins, offset by product innovation.
- **Strategic Acquisitions**: STAAR deal highlights Alcon's refractive-surgical integration strategy.


**【CEO Summary Section】**
- **Revenue Growth**: Q3 2025 revenue of $2.6 billion (+5% YoY), driven by Surgical (+5%) and Vision Care (+5%).
- **Unity VCS Momentum**: 1,200 placements YTD, with focus on training and workflow integration for efficiency gains.
- **Product Launch Success**: PanOptix Pro stabilizing U.S. trifocal IOL share, Tryptyr early adoption strong with prescriber uptake.
- **Acquisition Update**: STAAR Surgical deal remains attractive, though not critical to growth.

**【CFO Financial Commentary】**
- **Margins Under Pressure**: Core operating margin 20.2% (-60bps YoY) due to tariffs, R&D, and SG&A investments.
- **Free Cash Flow**: $1.2B YTD, supporting $550M shareholder returns (shares buyback + dividends).
- **Tariff Impact**: Q4 tariff-related charges to rise, with $50-100M incremental 2026 impact offset by FX and cost actions.
- **2026 Outlook**: 4-6% top-line growth, with margin expansion via product mix and cost control.

**【Q&A Highlights】**
- **Unity VCS**: Order book strong, placements pacing deliberate to ensure adoption.
- **Market Dynamics**: U.S. cataract volumes improving but still below historical 4% trend.
- **Tryptyr**: Early prescriber enthusiasm, though audited data lags digital platform adoption.
- **Competitive Landscape**: Intensified implantables competition, but Alcon maintains majority share.


Alcon Inc. (ALC) Q3 2025 Earnings Call Transcript

Revenue

Sales and Services Revenue

Financing Services Revenue

Other Revenue

Cost of Revenue

Cost of Goods and Services

Cost of Financing Services

Other Cost

Gross Profit

Other Operating Income

Operating Expenses

Selling, General and Administrative Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research and Development Expenses

Loss on Bad Debts

Loss on Impairment of Other Assets

Loss on Disposal of Assets

Other Operating Expenses

Operating Income

Non-Operating Income (Loss)

Income (Loss) from Affiliates

Income (Loss) from Associates

Income (Loss) from Joint ventures

Gain (Loss) on Other Investment

Gain (Loss) on Change in Fair Value

Gain (Loss) on Foreign Currency Exchange

Other Non-Operating Income (Loss)

Net Interest Expense

Interest Expense

Interest Income

Pretax Income From Continuing Operations

Income Tax Expense

Current Income Tax

Deferred Income Tax

Income Tax Adjustments

Net Income from Continuing Operations

Income from Discontinued Operations

Other Items Before Net Income

Net Income

Net Income Attributable to Minority Interests

Net Income Attributable to Owners of the Company

Preferred Stock Dividends

Other Adjustments

Net Income Attributable to Common Stockholders

Other Comprehensive Income

Total Comprehensive Income

Total Comprehensive Income Attributable to Minority Interests

Total Comprehensive Income Attributable to Owners of the Company

Basic EPS

Basic EPS from Continuing Operations

Basic EPS from Discontinued Operations

Diluted EPS

Diluted EPS from Continuing Operations

Diluted EPS from Discontinued Operations

ALC

ALC fundamentals

You can ask Aime